Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma (Everolimage)

Share this content:
Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma (Everolimage)

Sponsors and Collaborators
University Medical Centre Groningen
Novartis

Contact
Sjoukje Oosting, MD
+ 31 50 3612821
s.oosting@int.umcg.nl

Jourik Gietema, MD PhD
+31 50 3612821
j.a.gietema@int.umcg.nl

Principal Investigator
Sjoukje Oosting, MD, University Medical Centre Groningen

ClinicalTrials.gov Identifier
NCT01028638

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters